BenignSyndrome
Beckwith-Wiedemann Syndrome
Synonyms: EMG Syndrome, exomphalos-macroglossia-gigantism
SYSTEMIC GENETIC Syndrome
Quick Facts
Behaviour
Benign
Category
Syndrome
Grade
Not set
Synonyms
- EMG Syndrome
- exomphalos-macroglossia-gigantism
Category
Syndrome
Behaviour
Benign
Gender
Both equally
Epidemiology
- Autosomal dominant genetic disorder (imprinting disorder)
- Incidence 1 in 13,700 live births
- 50% familial, 50% sporadic
- Increased risk of childhood malignancies (1-5%)
- Beckwith-Wiedemann region (11p15) imprinting dysregulation
Clinical Features
- Macroglossia (enlarged tongue)
- Exomphalos/omphalocele
- Gigantism/overgrowth
- Facial nevus flammeus
- Hemihypertrophy
- Ear abnormalities (creases, pits)
- Hypoglycaemia in neonatal period
Location
- Generalized overgrowth affecting all body parts
- Tongue, abdominal wall, kidneys, adrenal glands
- Wilms tumour (kidney)
- Hepatoblastoma
- Rhabdomyosarcoma
Imaging
- Prenatal ultrasound: macrosomia, exomphalos
- MRI: assess tongue size and airway
- Abdominal imaging: screen for Wilms tumour
- Baseline and periodic screening imaging
Pathology
- Not applicable to Syndrome itself
- Histology if associated tumours present
Genetics
- 11p15 imprinting defects: loss of methylation on IC2, gain on IC1
- CDKN1C mutations in some familial cases
- H19 and IGF2 dysregulation
- Genomic imprinting disorder
Treatment
- Multidisciplinary management
- Tongue reduction if macroglossia severe
- Surgical repair of exomphalos
- Management of hypoglycaemia
- Surveillance for tumours
Prognosis
- Good survival with appropriate management
- Depends on associated complications
- Tumour risk Highest age 0-5 years
Key Points
- SYSTEMIC GENETIC Syndrome
- Increased malignancy risk requires surveillance
- Macroglossia and exomphalos characteristic
- Imprinting disorder on 11p15
Workup - Blood Tests
- Glucose monitoring (neonatal)
- FBC, U&E (baseline)
- No specific diagnostic blood test
Workup - Local Imaging
- Prenatal ultrasound if familial history
- Abdominal ultrasound: screen for Wilms, hepatoblastoma
- Baseline imaging before age 5 years
Workup - Biopsy
Not applicable to Syndrome diagnosis
Workup - Staging
Abdominal ultrasound: screen for Wilms, hepatoblastoma
Workup - Other
- Genetics consultation mandatory
- Paediatric surgery consultation
- ENT for macroglossia assessment
- Oncology surveillance protocol
Follow-up Summary
- Regular abdominal imaging every 3 months until age 5 years (Wilms/hepatoblastoma screening)
- Genetic counselling for family
- Monitor for other malignancies beyond age 5 years
- Feeding and speech assessment